MAJOR COLLABORATIONS
- UMR –CNRS 8199, P. Froguel (Lille), since 2007
- MAGIC (Meta-Analyses of Glucose and Insulin-related traits Consortium), since 2008
- CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology), since 2013
- Queen Mary University of London (QMU), Panos Deloukas, since 2013
- Wellcome Trust Sanger Institute (WTSI), Eleftheria Zeggini,since 2013
- National Heart Lung and Blood Institute (NHLBI), Sudha Seshadri and Ramashandran Vasan,since 2010
- University Medical Center of Groningen (UMCG), Behrooz Alizadeh,since 2013
- Social Science Genetics Association Consortium for Reproductive Behavior, University of Groningen, Jornt Mandemakers et Nicola Barban,since 2013
COLLABORATION WITH RANDOX
Our collaborations with industries of the diagnostic fielsd, and more specificly with RANDOX (Belfast, Irland) consists in the development of diagnostic tools for biomarkers of blood pressure, metabolic syndrome, VEGF-A and pharmacogenomics. Our collaboration with RANDOX also concerns the set-up of multiplex essays for hypertension early prediction biomarkers. The transfert of scientific results to diagnostic and technologic innovation is in progress thanks to 2 patents.
- WO 2014006231 A1: "Association of Vascular Endothelial Growth Factor Genetic Variant with Metabolic Syndrome": http://patents.google.com/patent/WO2014006231A1/en (Inventor: Sophie VISVIKIS-SIEST) - 2014.
- WO 2013093091 A2: "Genetic Factors in Blood Pressure" http://patents.google.com/patent/WO2013093091A2/en (Inventors: Sophie VISVIKIS-SIEST, Said EL SHAMIEH, Helena MURRAY, John LAMONT, Peter FITZGERALD) - 2013.
Le consortium VEGF - « Vascular Endothelial Growth Factor European Genomic Federation » réunissant 20 partenaires (https://www.santoriniconference.org/)